← Back to Search

Behavioral Intervention

SHINE Intervention for Substance Use Disorders and Family Planning

N/A
Waitlist Available
Led By Deborah Rinehart, PhD, MA
Research Sponsored by Denver Health and Hospital Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
In treatment for substance use disorder at one of the participating clinics
18-44 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial will test a new intervention to help patients in recovery from substance use disorder connect to reproductive health education and services.

Who is the study for?
This trial is for English-speaking individuals aged 18-44 in the Denver area, who can become pregnant and are not currently pregnant. They must be in treatment for substance use disorder at a participating clinic and not planning to move away within the next three months.Check my eligibility
What is being tested?
The study is testing a health educator intervention called SHINE, aimed at linking people recovering from substance use disorders with reproductive health education and services. The feasibility and acceptability of this program will be evaluated.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments or drugs, there are no direct physical side effects expected from participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently receiving treatment for substance use at a participating clinic.
Select...
I am between 18 and 44 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention sessions completed.
Self-reported satisfaction with intervention.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Health Educator InterventionExperimental Treatment1 Intervention
As the population of focus in this study is diverse, including men and women regardless of pregnancy desire, the primary focus for the intervention for this study will be education, particularly for men. All participants that enroll in the study will be offered the intervention. The study health educator will use the PATH (Parenthood/Pregnancy Attitude, Timing, and How) framework questions to initially guide the conversation. Depending on the participant's desires, the educator will provide education on other topics such as sexually transmitted infections (STIs) and we will also navigate to clinical services as needed. The health educator will use a study manual to guide all intervention activities including engagement. Additionally, the health educator will collect data on intervention outreach, engagement, topics discussed, participant needs and outcomes.

Find a Location

Who is running the clinical trial?

Denver Health and Hospital AuthorityLead Sponsor
101 Previous Clinical Trials
400,198 Total Patients Enrolled
Department of Health and Human ServicesFED
226 Previous Clinical Trials
928,750 Total Patients Enrolled
Deborah Rinehart, PhD, MAPrincipal Investigator - Denver Health & Hospital Authority
Denver Health and Hospital Authority

Media Library

Sexual Health Initiative for Navigation and Education (SHINE) Health Educator Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04162184 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings left in this research project?

"Per clinicaltrials.gov, this trial does not have an open call for participants at present; the study was first published on December 16th 2019 and has most recently been updated on November 29th 2022. Nonetheless, there are 1199 other ongoing medical trials that require volunteers to participate."

Answered by AI

Is this clinical research open to participants of over thirty years in age?

"To participate in this clinical trial, applicants must be between 18 and 44 years old. By contrast, there are 318 studies available for those below the legal age of consent, as well as 800 trials specifically geared towards seniors aged 65 or older."

Answered by AI

Does the study allow for my participation?

"The age requirements for this trial are between 18 and 44, while 199 patients need to be enrolled. Additionally, those wishing to join must possess satisfactory sexual health."

Answered by AI

Who else is applying?

What site did they apply to?
Denver Health & Hospital Authority
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

Im ready to put addiction behind me and move on for my kids and me!
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder
Deborah Rinehart 2019. "Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04162184.
All > Substance Abuse
~37 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top